CIK 0001815776 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LENZ Therapeutics, Inc.
Sign in to watch- Ticker
- LENZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844867570
- Phone
- 858-925-7000
- Business address
- 201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
- Former names
- Graphite Bio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,134,778
- in 1 filing
Net −$9,134,778. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-19 | KARSEN PERRY A Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-19 | JIMENEZ JOSEPH Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-19 | Jerel Davis Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-19 | Carlo Rizzuto Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-19 | Bassan Abraham Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-19 | Shah Smital Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-19 | Hege Kristen Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-02-21 | Young Alethia Chief Financial Officer | Grant or award · Stock Option (right to buy) | +220,000 | 220,000 | ||
| 2023-02-21 | Lehrer-Graiwer Joshua PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2022-06-21 | Viney Joanne L. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-21 | Porteus Matthew Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-21 | KARSEN PERRY A Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-21 | JIMENEZ JOSEPH Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-21 | Jerel Davis Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-21 | Carlo Rizzuto Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-21 | Bassan Abraham Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-21 | Shah Smital Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-21 | Hege Kristen Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-04-12 | Samsara BioCapital, L.P. 10% owner | Purchase | +350,000 | $4.08 | $1.4M | 8,459,314 |
| 2022-04-11 | Samsara BioCapital, L.P. 10% owner | Purchase | +74,464 | $4.07 | $303K | 8,109,314 |
Page 7 of 11 · 217 trades